Literature DB >> 18253817

A physiological model to evaluate drug kinetics in patients with hemorrhagic shock followed by fluid resuscitation. Application to amoxicillin-clavulanate.

Michel Tod1, Franck Lagneau, Vincent Jullien, Olivier Mimoz.   

Abstract

PURPOSE: To build a physiologically based pharmacokinetic model describing drug kinetics in interstitial fluid in case of hemorrhagic shock, and to propose a simple method to determine the subset of influential parameters that may be estimated with the data at hand.
METHODS: The model, which accounts for alterations of regional blood flows and body water distribution, was fitted to amoxicillin and clavulanate kinetic data, assessed in 12 trauma patients with hemorrhagic shock by comparison with 12 healthy volunteers. The predictions were the free concentrations of amoxicillin and clavulanate in 14 organs.
RESULTS: In all tissues of trauma patients, the rate of distribution was lower, but the steady-state level was higher than those in healthy participants. Blood volume was reduced by 25% and blood flow in organs other than lung, brain, and heart were reduced by 18%. Compared with healthy subjects, the time that free amoxicillin concentration remained above 8 mg/L in the interstitial fluid of trauma patients was higher in blood and muscles, and lower in the tendon compartment.
CONCLUSIONS: The results and predictions were consistent with the knowledge in this field. The model may be useful to optimize clinical trial designs and drug dosing regimens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253817     DOI: 10.1007/s11095-008-9546-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

1.  Ex vivo 12 h bactericidal activity of oral co-amoxiclav (1.125 g) against beta-lactamase-producing Haemophilus influenzae.

Authors:  S Bronner; D Pompei; H Elkhaïli; N Dhoyen; H Monteil; F Jehl
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

Review 2.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 3.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Lumping of whole-body physiologically based pharmacokinetic models.

Authors:  I A Nestorov; L J Aarons; P A Arundel; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

5.  Simulation of linear compartment models with application to nuclear medicine kinetic modeling.

Authors:  D Z D'Argenio; A Schumitzky; W Wolf
Journal:  Comput Methods Programs Biomed       Date:  1988 Jul-Aug       Impact factor: 5.428

Review 6.  [Consensus conference. "Antibioprophylaxis in a surgical setting". 10-11 December 1992, Faculté de Médecine Xavier Bichat].

Authors: 
Journal:  Cah Anesthesiol       Date:  1993

7.  A physiologically based, recirculatory model of the kinetics and dynamics of propofol in man.

Authors:  Richard N Upton; Guy Ludbrook
Journal:  Anesthesiology       Date:  2005-08       Impact factor: 7.892

8.  In vivo determination of steric and electrostatic exclusion of albumin in rat skin and skeletal muscle.

Authors:  Christina C Gyenge; Olav Tenstad; Helge Wiig
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

9.  The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.

Authors:  Ken B Johnson; Talmage D Egan; Steven E Kern; Julia L White; Scott W McJames; Noah Syroid; Derek Whiddon; Ty Church
Journal:  Anesthesiology       Date:  2003-08       Impact factor: 7.892

10.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?

Authors:  D Gallagher; M Visser; D Sepúlveda; R N Pierson; T Harris; S B Heymsfield
Journal:  Am J Epidemiol       Date:  1996-02-01       Impact factor: 4.897

View more
  4 in total

Review 1.  Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.

Authors:  K Sandy Pang; Matthew R Durk
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-14       Impact factor: 2.745

2.  A physiologically-based recirculatory meta-model for nasal fentanyl in man.

Authors:  Richard N Upton; David J R Foster; Lona L Christrup; Ola Dale; Kristin Moksnes; Lars Popper
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-19       Impact factor: 2.745

3.  Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results.

Authors:  Marylore Chenel; François Bouzom; Fanny Cazade; Kayode Ogungbenro; Leon Aarons; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-01-07       Impact factor: 2.745

Review 4.  The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.

Authors:  Alicia Rodríguez-Gascón; María Ángeles Solinís; Arantxa Isla
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.